Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Introduction and overview of therapeutic apheresis.

Literature DB >> 20806281

Introduction and overview of therapeutic apheresis.

Chidi Okafor¹, David M Ward, Michele H Mokrzycki, Robert Weinstein, Pamela Clark, Rasheed A Balogun.

Abstract

Mesh：

Substances：
ABO Blood-Group System

Year: 2010 PMID： 20806281 DOI： 10.1002/jca.20247

Source DB: PubMed Journal: J Clin Apher ISSN： 0733-2459 Impact factor: 2.821

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

Review 1. Principles of separation: indications and therapeutic targets for plasma exchange.

Authors: Mark E Williams; Rasheed A Balogun
Journal: Clin J Am Soc Nephrol Date: 2013-10-31 Impact factor: 8.237

2. Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.

Authors: Lidia Stork; David Ellenberger; Tim Beißbarth; Tim Friede; Claudia F Lucchinetti; Wolfgang Brück; Imke Metz
Journal: JAMA Neurol Date: 2018-04-01 Impact factor: 18.302

Review 3. Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management.

Authors: Yolanda W Ng; Manpreet Singh; Minnie M Sarwal
Journal: Drugs Date: 2015-04 Impact factor: 9.546

Review 4. Treatment options and strategies for antibody mediated rejection after renal transplantation.

Authors: Matthew H Levine; Peter L Abt
Journal: Semin Immunol Date: 2011-09-21 Impact factor: 11.130

5. No association between frequent apheresis donation and risk of fractures: a retrospective cohort analysis from Sweden.

Authors: Katrine Grau; Senthil K Vasan; Klaus Rostgaard; Walter Bialkowski; Rut Norda; Henrik Hjalgrim; Gustaf Edgren
Journal: Transfusion Date: 2016-11-18 Impact factor: 3.157

10. Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels.

Authors: Su-Hyun Kim; Woojun Kim; So-Young Huh; Kyue Yim Lee; In Ja Jung; Ho Jin Kim
Journal: J Clin Neurol Date: 2013-01-03 Impact factor: 3.077

Introduction and overview of therapeutic apheresis.

Review 1. Principles of separation: indications and therapeutic targets for plasma exchange.

2. Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.

Review 3. Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management.

Review 4. Treatment options and strategies for antibody mediated rejection after renal transplantation.

5. No association between frequent apheresis donation and risk of fractures: a retrospective cohort analysis from Sweden.

6. Plasma exchange: an effective add-on treatment of optic neuritis in neuromyelitis optica spectrum disorders.

7. Safety and efficacy of tandem hemodialysis and plasma exchange in children.

Review 8. Therapeutic Plasma Exchange Using Membrane Plasma Separation.

9. Therapeutic plasma exchange decreases levels of routinely used cardiac and inflammatory biomarkers.

10. Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels.